Hims & Hers Health Inc - Ordinary Shares - Class A
HIMS
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
258.5% upsideUndervalued by 258.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.19 Billion |
|---|---|
| Enterprise Value | $7.27 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.57 |
| Beta | 2.34 |
| Outstanding Shares | 228,357,303 |
Return
| Return on Equity | -2.97% |
|---|---|
| Return on Assets | -0.58% |
| Return on Invested Capital | 2.48% |
Valuation & Multiples
| P/E Ratio | -555.4 |
|---|---|
| PEG | 194.1 |
| Price to Sales | 2.78 |
| Price to Book Ratio | 27.77 |
| Enterprise Value to Revenue | 3.07 |
| Enterprise Value to EBIT | 178.05 |
| Enterprise Value to Net Income | -550 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 2.91 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.8588▲ 6.56% |
|---|---|
| Total Calls | 122,500▼ 99.66% |
| Total Puts | 105,200▼ 99.63% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.61%▼ 63.15% |
|---|---|
| Total Invested | $206.70M▼ 93.32% |
| Investors Holding | 153▼ 335.00% |
ESG Score
No data
About Hims & Hers Health Inc
181 employeesHims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermato...
Relevant Senate Committees
Controls taxation, trade, and entitlement spending (e.g., Medicare, Medicaid), directly impacting HIMS's profitability through tax policy and significantly influencing the broader healthcare payment landscape and market demand.
Controls federal spending allocations, including potential funding for healthcare programs or research that could directly impact the market for HIMS's services, especially if government programs are a significant payer or competitor.
Direct oversight of the FDA (critical for health products and tele-prescribed medications), NIH, and broader healthcare and labor laws directly impacts HIMS's operations, service offerings, and regulatory environment.
Direct oversight of interstate commerce, consumer protection (FTC), data privacy, and potentially telecommunications (FCC) are critical for a national telehealth platform operating across state lines and handling sensitive consumer data.